Registry-based randomised clinical trials: a remedy for evidence-based diabetes care? Jan W. ErikssonBjörn EliassonJohan Sundström Review Open access 29 July 2022 Pages: 1575 - 1586
Intestinal lipid absorption and transport in type 2 diabetes Bruno Vergès Review 30 July 2022 Pages: 1587 - 1600
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review Clementine E. M. VerhulstTherese W. Fabriciuson behalf of the Hypo-RESOLVE consortium Article Open access 22 July 2022 Pages: 1601 - 1612
Metagenomic analysis reveals crosstalk between gut microbiota and glucose-lowering drugs targeting the gastrointestinal tract in Chinese patients with type 2 diabetes: a 6 month, two-arm randomised trial Xiuying ZhangHuahui RenLinong Ji Article Open access 05 August 2022 Pages: 1613 - 1626
Gut microbiota mediate melatonin signalling in association with type 2 diabetes Xueran HuangYang QiuRui Lin Article 30 June 2022 Pages: 1627 - 1641
Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality Xue BaoBiao XuGunnar Engström Article Open access 04 August 2022 Pages: 1642 - 1651
Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank Robyn J. TappChristopher G. Owenon behalf of the UK Biobank Eyes and Vision Consortium Article Open access 19 July 2022 Pages: 1652 - 1663
Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study Jie ZhengMin XuYufang Bi Article Open access 29 July 2022 Pages: 1664 - 1675
Assessment of the bi-directional relationship between blood mitochondrial DNA copy number and type 2 diabetes mellitus: a multivariable-adjusted regression and Mendelian randomisation study Wenyi WangJiao LuoRaymond Noordam Article Open access 22 July 2022 Pages: 1676 - 1686
Islet amyloid polypeptide aggregation exerts cytotoxic and proinflammatory effects on the islet vasculature in mice Joseph J. CastilloAlfred C. AplinRebecca L. Hull Article 25 July 2022 Pages: 1687 - 1700
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage Amir-Babak Sioofy-KhojineSarah J. RichardsonMartin Eichmann Article Open access 22 July 2022 Pages: 1701 - 1709
Three weeks of time-restricted eating improves glucose homeostasis in adults with type 2 diabetes but does not improve insulin sensitivity: a randomised crossover trial Charlotte AndriessenCiarán E. FealyPatrick Schrauwen Article Open access 25 July 2022 Pages: 1710 - 1720
Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes Jayron J. HabibeMaria P. Clemente-OlivoCarlie J. M. de Vries Article Open access 08 July 2022 Pages: 1721 - 1733
ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes Emma M. LessieurHaitao LiuTimothy S. Kern Article 19 July 2022 Pages: 1734 - 1744
Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes Kouji H. HaradaMariko Harada Sassa Letter 16 July 2022 Pages: 1745 - 1746
Potential confounders in the association between per- and polyfluoroalkyl substance exposure and diabetes. Reply to Harada KH, Harada Sassa M [letter] Sung Kyun ParkXin WangCarrie A. Karvonen-Gutierrez Letter 18 July 2022 Pages: 1747 - 1750
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question Mitch Kanter Letter Open access 16 August 2022 Pages: 1751 - 1752
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter] Fenglei WangMegu Y. BadenFrank B. Hu Letter 13 August 2022 Pages: 1753 - 1754
